FDA Archives - Page 2 of 2 - Cannabis Business Executive - Cannabis and Marijuana industry news

Understanding Potential CBD Users; Drivers to Adoption

March 5, 2019
Mike Luce
Cannabis & Hemp Research, Hemp Industry News, Marketing
0 Comments

In recent weeks, this space has seen several contributions from High Yield Insights to the ongoing conversation in the industry on cannabidiol. Dating back to a high-level review of the CBD consumer in July 2018, our approach has to evaluate…

Marijuana gives you the munchies. What about CBD?

As a dietitian, I always receive an influx of New Year’s emails predicting upcoming food trends. This year, several experts have forecast an increase in foods and beverages containing cannabidiol, a chemical compound found in cannabis plants. More colloquially called…

Surgeon General Believes It’s High Time For Marijuana Reclassification

At the close of 2018, the U.S. Surgeon General Jerome Adams made a bold move, and called on the federal government to rethink marijuana’s classification as a Schedule I substance. While the Surgeon General did not go so far as to condone…

Will Hemp-Derived CBD Be Fully Legal with Passage of the 2018 Farm Bill? Not Quite…

December 5, 2018
Ian Stewart
California, Cannabis Investments, Compliance and Regulations, Hemp Business Executive, Hemp Industry News, Hemp Policy & Legal, News & Insights, Policy & Legal
0 Comments

By Ian Stewart, Wilson Elser Public interest in the potential health benefits of CBD (cannabidiol) is responsible for a whole new market segment of health and wellness foods and supplements that features CBD as an ingredient. CBD is one of…

FDA Rejects Petition To Further Restrict Marijuana

July 6, 2018
AggregatedNews
Organizations & Associations, Policy & Legal
0 Comments

The U.S. Food and Drug Administration (FDA) has denied a request from an anti-legalization group to place marijuana and its derivatives on a list of restricted substances that are not "generally recognized as safe and effective." The move is "not…

‘No such thing as medical marijuana,’ Health Secretary says at Dayton-area visit

KETTERING — As Ohio prepares to launch its medical marijuana program by issuing licenses to cultivators, processors and dispensers, U.S. Health and Human Services Secretary Alex Azar said in Kettering today, “There really is no such thing as medical marijuana.” The…

Cannabis & Sports With Orthopaedic Surgeon Dr. Charles Bush-Joseph

It was my good fortune recently to interview Dr. Charles Bush-Joseph. Dr. Bush-Joseph is the team physician for the Chicago White Sox, Associate Team Physician for the Chicago Bulls and he is currently a Professor at Rush University Medical Center as…

Anti-Legalization Big Pharma Company Has Their Synthetic THC Drug Approved By FDA

Insys Therapeutics, a pharmaceutical company that was one of the chief financial backers of the opposition to marijuana legalization in Arizona last year, received preliminary approval from the Drug Enforcement Administration this week for Syndros, a synthetic marijuana drug. Insys gave $500,000…

Big Pharma Seeks to Capitalize on Pain-Reducing Compound Derived From Cannabis

The medicinal properties of cannabidiol (better known as CBD), a compound found in the Cannabis sativa L. plant species, are quickly drawing the attention of scientists, plant-medicine lovers, dietary-supplement companies, venture capitalists, professional athletes and Big Pharma -- not to…

FDA Approves Insys Therapeutics’ 2nd Cannabis-Based Drug

On June 21, Todd Hagopian recommended Insys Therapeutics (INSY). Since then, the stock has gained nearly 20%. After a stock runs like this, many investors are tempted to sell. However, in situations like this, I’ve found it valuable to know which side…

U.S. Pharmacopeial Convention: Analyzing the Need for Public Quality Standards for Medical Cannabis

Interesting things are taking place behind the scenes as cannabis prohibition moves to a grinding halt. Key organizations like U.S. Pharmacopeial Convention (USP), a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, food…